Table 2.
ALL HPV Doses | NO HPV Dose | |||||
---|---|---|---|---|---|---|
UOR | 95% CI | Sig | UOR | 95% CI | Sig | |
Sex | ||||||
Female | 4.85 | [2.47, 9.53] | *** | 0.41 | [0.26, 0.67] | *** |
Male (Ref) | ||||||
Race/Ethnicity | ||||||
Non-Hispanic White (Ref) | ||||||
African American | 0.39 | [0.16, 0.97] | * | 0.79 | [0.44, 1.42] | |
Hispanic | 0.47 | [0.23, 0.99] | * | 0.73 | [0.41, 1.29] | |
Other Race | 0.42 | [0.14, 1.24] | 0.49 | [0.17, 1.42] | ||
Age Group | ||||||
18–24 Years (Ref) | ||||||
25–29 Years | 1.30 | [0.73, 2.30] | 3.47 | [2.11, 5.70] | *** | |
Influenza Immunizations | ||||||
Yes, past year | 0.92 | [0.52, 1.61] | 0.53 | [0.32, 0.87] | * | |
No (Ref) | ||||||
Region | ||||||
Northeast | ||||||
Midwest | 0.72 | [0.45, 1.14] | 1.32 | [0.90, 1.93] | ||
South | 0.55 | [0.38, 0.80] | ** | 1.27 | [0.95, 1.71] | |
West | 0.80 | [0.49, 1.31] | 1.41 | [0.94, 2.10] |
Note: Based on 3,880 young adults in the age group 18–29 years from nine states and who did not have missing values in human papillomavirus vaccination variable. Significant group differences were tested with Rao-Scott chi-squares. UORs and 95% Cis are from unadjusted multinomial logistic regression on HPV receipt and adherence.
HPV: Human Papillomavirus Vaccination